Terug
Dagbereik
€ 31,25
€ 31,99
52-Weeksbereik
€ 9,22
€ 36,00
Volume
621.926
50D / 200D Gem.
€ 32,62
/
€ 22,22
Vorige Slotkoers
€ 30,78
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -104,9 | 0,4 |
| P/B | 12,8 | 2,9 |
| ROE % | -13,5 | 3,7 |
| Net Margin % | -7,0 | 3,9 |
| Rev Growth 5Y % | 15,3 | 10,0 |
| D/E | 0,2 | 0,2 |
Koersdoel Analisten
Hold
€ 38,38
+20.9%
Low: € 34,00
High: € 41,00
Forward K/W
61,9
Forward WPA
€ 0,51
WPA Groei (sch.)
+0,0%
Omzet Sch.
270 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 1,70
€ 1,68 – € 1,72
|
530 M | 1 |
| FY2029 |
€ 1,31
€ 1,29 – € 1,32
|
430 M | 1 |
| FY2028 |
€ 0,99
€ 0,98 – € 1,00
|
370 M | 2 |
Belangrijkste Punten
Revenue grew 15,32% annually over 5 years — strong growth
Debt/Equity of 0,15 — conservative balance sheet
Negative free cash flow of -2,93M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4,89%
Capital efficient — spends only 1,66% of revenue on capex
Groei
Revenue Growth (5Y)
15,32%
Revenue (1Y)20,21%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-13,49%
ROIC-3,98%
Net Margin-6,97%
Op. Margin-3,49%
Veiligheid
Debt / Equity
0,15
Current Ratio5,11
Interest Coverage-1,02
Waardering
P/E Ratio
-104,93
P/B Ratio12,79
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20,21% | Revenue Growth (3Y) | 19,01% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 15,32% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 225,21M | Net Income (TTM) | -15,70M |
| ROE | -13,49% | ROA | -7,08% |
| Gross Margin | 74,31% | Operating Margin | -3,49% |
| Net Margin | -6,97% | Free Cash Flow (TTM) | -2,93M |
| ROIC | -3,98% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,15 | Current Ratio | 5,11 |
| Interest Coverage | -1,02 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -104,93 | P/B Ratio | 12,79 |
| P/S Ratio | 7,32 | PEG Ratio | -2,01 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,65B | Enterprise Value | 1,63B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 225,21M | 187,34M | 159,01M | 138,58M | 127,36M |
| Net Income | -15,70M | -9,96M | -21,72M | -28,95M | -26,99M |
| EPS (Diluted) | -0,34 | -0,23 | -0,51 | -0,69 | -0,65 |
| Gross Profit | 167,35M | 141,98M | 121,87M | 108,81M | 104,43M |
| Operating Income | -7,85M | -3,29M | -21,46M | -29,71M | -25,42M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 221,69M | 203,73M | 196,83M | 195,39M | 208,02M |
| Total Liabilities | 92,84M | 99,82M | 101,16M | 94,39M | 95,47M |
| Shareholders' Equity | 128,85M | 103,91M | 95,67M | 101,00M | 112,55M |
| Total Debt | 19,24M | 68,69M | 69,29M | 67,43M | 67,45M |
| Cash & Equivalents | 35,55M | 27,55M | 31,02M | 15,28M | 32,76M |
| Current Assets | 120,42M | 99,22M | 88,00M | 98,08M | 127,05M |
| Current Liabilities | 23,56M | 30,61M | 30,43M | 23,75M | 24,29M |